Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Fusi

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Future Oncology (London, England)|August 5, 2017
The importance for immunoregulation for long-term cancer controlAlberto Fusi, Angus Dalgleish
Journal of Translational Medicine|August 16, 2018
Enhanced effect of checkpoint inhibitors when given after or together with IMM-101: significant responses in four advanced melanoma patients with no additional major toxicityAngus G Dalgleish, Satvinder Mudan, Alberto Fusi
Melanoma Research|July 4, 2014
Vemurafenib-induced nonautoimmune haemolytic anaemiaAlberto Fusi, Jackie Hodgetts, Mike Dennis, et al.
Melanoma Management|September 8, 2018
Dabrafenib and its use in the treatment of metastatic melanomaSamantha Bowyer, Rebecca Lee, Alberto Fusi, et al.
European Journal of Cancer (Oxford, England : 1990)|May 17, 2011
Enhanced detection of BRAF-mutants by pre-PCR cleavage of wild-type sequences revealed circulating melanoma cells heterogeneityAlberto Fusi, Rebecca Berdel, Swantje Havemann, et al.
Lung Cancer (Amsterdam, Netherlands)|March 18, 2015
Optimal management of immune-related toxicities associated with checkpoint inhibitors in lung cancerMatthew Howell, Rebecca Lee, Samantha Bowyer, et al.
Lung Cancer (Amsterdam, Netherlands)|April 29, 2008
Oxaliplatin doublets in non-small cell lung cancer: a literature reviewDiego Cortinovis, Paolo Bidoli, Nicoletta Zilembo, et al.
Current Treatment Options in Oncology|September 3, 2013
Clinical utility of circulating tumour cell detection in non-small-cell lung cancerAlberto Fusi, Robert Metcalf, Matthew Krebs, et al.
Melanoma Research|November 16, 2020
Life-threatening polymyositis with spontaneous hematoma induced by nivolumab in a patient with previously resected melanomaWing K Liu, Nabeel Naban, Arvind Kaul, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 19, 2012
Biclonal non-small cell lung cancer in disseminated tumor cells and tissueAnna Puggina, Verena Kümmerlen, Korinna Jöhrens-Leder, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Future Oncology (London, England)|August 5, 2017
The importance for immunoregulation for long-term cancer controlAlberto Fusi, Angus Dalgleish
Journal of Translational Medicine|August 16, 2018
Enhanced effect of checkpoint inhibitors when given after or together with IMM-101: significant responses in four advanced melanoma patients with no additional major toxicityAngus G Dalgleish, Satvinder Mudan, Alberto Fusi
Melanoma Research|July 4, 2014
Vemurafenib-induced nonautoimmune haemolytic anaemiaAlberto Fusi, Jackie Hodgetts, Mike Dennis, et al.
Melanoma Management|September 8, 2018
Dabrafenib and its use in the treatment of metastatic melanomaSamantha Bowyer, Rebecca Lee, Alberto Fusi, et al.
European Journal of Cancer (Oxford, England : 1990)|May 17, 2011
Enhanced detection of BRAF-mutants by pre-PCR cleavage of wild-type sequences revealed circulating melanoma cells heterogeneityAlberto Fusi, Rebecca Berdel, Swantje Havemann, et al.
Lung Cancer (Amsterdam, Netherlands)|March 18, 2015
Optimal management of immune-related toxicities associated with checkpoint inhibitors in lung cancerMatthew Howell, Rebecca Lee, Samantha Bowyer, et al.
Lung Cancer (Amsterdam, Netherlands)|April 29, 2008
Oxaliplatin doublets in non-small cell lung cancer: a literature reviewDiego Cortinovis, Paolo Bidoli, Nicoletta Zilembo, et al.
Current Treatment Options in Oncology|September 3, 2013
Clinical utility of circulating tumour cell detection in non-small-cell lung cancerAlberto Fusi, Robert Metcalf, Matthew Krebs, et al.
Melanoma Research|November 16, 2020
Life-threatening polymyositis with spontaneous hematoma induced by nivolumab in a patient with previously resected melanomaWing K Liu, Nabeel Naban, Arvind Kaul, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 19, 2012
Biclonal non-small cell lung cancer in disseminated tumor cells and tissueAnna Puggina, Verena Kümmerlen, Korinna Jöhrens-Leder, et al.
Pageof 5